| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700017 | 重组全人源抗TNF-α单抗注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-09-14 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2018-09-03 | view |